Notice Information
Notice Title
NP35925 Cardiovascular & Respiratory Medicines
Notice Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Information
Epoprostenol Powder and Solvent (pH 10.5) for Solution for Infusion Vials
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion VialsSupply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Epinephrine (Adrenaline) Pre-Filled SyringesSupply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Epinephrine (Adrenaline) Auto Injector DevicesSupply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Enoxaparin Sodium InjectionSupply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Urokinase InjectionsSupply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Isosorbide Mononitrate Modified-Release (M/R) Capsules and TabletsSupply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Diltiazem Hydrochloride Modified-Release (M/R) Capsules and TabletsSupply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Verapamil Hydrochloride Modified-Release (M/R) Capsules and TabletsSupply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Nifedipine Modified-Release (M/R) Capsules and TabletsSupply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Theophylline Modified-Release (M/R) Capsules and TabletsSupply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Branded and Branded Generic InhalersSupply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Iloprost MedicinesSupply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Dalteparin InjectionsSupply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Tinzaparin Sodium InjectionsSupply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Icatibant Solution for InjectionSupply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Treprostinil InjectionSupply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Direct Acting Oral Anticoagulants (DOACs)Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
All Other Cardiovascular & Respiratory MedicinesSupply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-04afa6
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/019020-2025
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £95,148,458 £10M-£100M
- Lots Value
- £95,148,450 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £82,305,880 £10M-£100M
Notice Dates
- Publication Date
- 6 May 20259 months ago
- Submission Deadline
- 20 Nov 2024Expired
- Future Notice Date
- Not specified
- Award Date
- 6 Apr 202510 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Active, Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Contact Name
- Not specified
- Contact Email
- marta.siwek@nhs.scot
- Contact Phone
- +44 07483141961
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-04afa6-2025-05-06T11:14:07+01:00",
"date": "2025-05-06T11:14:07+01:00",
"ocid": "ocds-h6vhtk-04afa6",
"description": "The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty six (36) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:795893)",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-04afa6",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NP35925 Cardiovascular & Respiratory Medicines",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a \"Lot\". Full details of each Lot is contained in section II.2 of this notice.",
"value": {
"amount": 95148458,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"title": "Epoprostenol Powder and Solvent (pH 10.5) for Solution for Infusion Vials",
"description": "Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 100000,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "2",
"title": "Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials",
"description": "Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 4541953,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "3",
"title": "Epinephrine (Adrenaline) Pre-Filled Syringes",
"description": "Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1555316,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "4",
"title": "Epinephrine (Adrenaline) Auto Injector Devices",
"description": "Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 813471,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "5",
"title": "Enoxaparin Sodium Injection",
"description": "Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 15288661,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "6",
"title": "Urokinase Injections",
"description": "Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 472523,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "7",
"title": "Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets",
"description": "Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 191878,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "8",
"title": "Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"description": "Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 119355,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "9",
"title": "Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"description": "Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 62465,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "10",
"title": "Nifedipine Modified-Release (M/R) Capsules and Tablets",
"description": "Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 136569,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "11",
"title": "Theophylline Modified-Release (M/R) Capsules and Tablets",
"description": "Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 32341,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "12",
"title": "Branded and Branded Generic Inhalers",
"description": "Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 4897823,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "13",
"title": "Iloprost Medicines",
"description": "Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1572128,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "14",
"title": "Dalteparin Injections",
"description": "Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 17380231,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "15",
"title": "Tinzaparin Sodium Injections",
"description": "Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 836630,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "16",
"title": "Icatibant Solution for Injection",
"description": "Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 381184,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "17",
"title": "Treprostinil Injection",
"description": "Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 283678,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "18",
"title": "Direct Acting Oral Anticoagulants (DOACs)",
"description": "Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 12053015,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "19",
"title": "All Other Cardiovascular & Respiratory Medicines",
"description": "Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 34429229,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1080
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "8"
},
{
"id": "9",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "9"
},
{
"id": "10",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "10"
},
{
"id": "11",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "11"
},
{
"id": "12",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "12"
},
{
"id": "13",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "13"
},
{
"id": "14",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "14"
},
{
"id": "15",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "15"
},
{
"id": "16",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "16"
},
{
"id": "17",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "17"
},
{
"id": "18",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "18"
},
{
"id": "19",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "19"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.",
"appliesTo": [
"supplier"
]
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder's carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2024-11-20T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2024-11-20T12:00:00Z"
},
"bidOpening": {
"date": "2024-11-20T12:00:00Z"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
},
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages."
},
"parties": [
{
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"address": {
"streetAddress": "1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07483141961",
"email": "marta.siwek@nhs.scot",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
}
},
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma",
"identifier": {
"legalName": "Martindale Pharma"
},
"address": {
"streetAddress": "Bampton Road, Harold Hill",
"locality": "Romford",
"region": "UK",
"postalCode": "RM3 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 7891785953"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-11330",
"name": "GlaxoSmithKline",
"identifier": {
"legalName": "GlaxoSmithKline"
},
"address": {
"streetAddress": "980 Great West Road",
"locality": "Brentford",
"region": "UK",
"postalCode": "TW8 9GS",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
},
"additionalContactPoints": [
{
"telephone": "+44 0800221441"
}
]
},
{
"id": "GB-FTS-11719",
"name": "Aventis Pharma Ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma Ltd t/a Sanofi"
},
"address": {
"streetAddress": "One Onslow Street",
"locality": "Guildford",
"region": "UK",
"postalCode": "GU1 4YS",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 08000352525"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd",
"identifier": {
"legalName": "Selective Supplies Ltd"
},
"address": {
"streetAddress": "The Priory, Syresham Gardens",
"locality": "Haywards Heath",
"region": "UK",
"postalCode": "RH16 3LB",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-92087",
"name": "Accord",
"identifier": {
"legalName": "Accord"
},
"address": {
"streetAddress": "Castlewood, 77-91 New Oxford Street",
"locality": "London",
"region": "UK",
"postalCode": "WC1A 1DG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01271385200",
"faxNumber": "+44 01271385200"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-88173",
"name": "Colonis Pharma Ltd",
"identifier": {
"legalName": "Colonis Pharma Ltd"
},
"address": {
"streetAddress": "Hanover Place, 8 Church Road",
"locality": "Royal Tunbride Wells",
"region": "UK",
"postalCode": "TN1 1JP",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 02039070830"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-33719",
"name": "Pfizer Limited",
"identifier": {
"legalName": "Pfizer Limited"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road",
"locality": "Tadworth",
"region": "UK",
"postalCode": "KT20 7NS",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07748322101"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146743",
"name": "Northumbria Healthcare NHS Foundation Trust",
"identifier": {
"legalName": "Northumbria Healthcare NHS Foundation Trust"
},
"address": {
"streetAddress": "Northumbria House, 7 - 8 Silver Fox Way, Cobalt Business Park,",
"locality": "Newcastle Upon Tyne",
"region": "UK",
"postalCode": "NE27 0QJ",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01912031587"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd",
"identifier": {
"legalName": "Dr Reddy's Laboratories (UK) Ltd"
},
"address": {
"streetAddress": "410, Cambridge Science Park,, Milton Road, Milton,",
"locality": "Cambridge",
"region": "UK",
"postalCode": "CB4 0PE",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07717467751"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-146744",
"name": "Aspire",
"identifier": {
"legalName": "Aspire"
},
"address": {
"streetAddress": "Deanshaugh House, Waterside",
"locality": "Elgin",
"region": "UK",
"postalCode": "IV30 4NU",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 7762394281"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-11344",
"name": "Focus Pharmaceuticals Ltd",
"identifier": {
"legalName": "Focus Pharmaceuticals Ltd"
},
"address": {
"streetAddress": "5 Faraday Court, Centrum 100, First Avenue",
"locality": "Burton upon Trent",
"region": "UK",
"postalCode": "DE14 2WX",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01283495280"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-11339",
"name": "Aguettant Ltd",
"identifier": {
"legalName": "Aguettant Ltd"
},
"address": {
"streetAddress": "No 1 Farleigh House, Flax Bourton",
"locality": "Bristol",
"region": "UK",
"postalCode": "BS48 1UR",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01275463691",
"faxNumber": "+44 08443650050"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-88174",
"name": "Day Lewis Medical Ltd",
"identifier": {
"legalName": "Day Lewis Medical Ltd"
},
"address": {
"streetAddress": "Day Lewis House, 2 Peterwood Way",
"locality": "Croydon",
"region": "UK",
"postalCode": "CR0 4UQ",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07860379358"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-88176",
"name": "Techdow Pharma England Ltd",
"identifier": {
"legalName": "Techdow Pharma England Ltd"
},
"address": {
"streetAddress": "Surrey Research Park Office, Surrey Technology Centre, 40 Occam Road",
"locality": "Guildford",
"region": "UK",
"postalCode": "GU2 7YG",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146745",
"name": "Venipharm LTD",
"identifier": {
"legalName": "Venipharm LTD"
},
"address": {
"streetAddress": "Room 130, Building 1, Chalfont Park",
"locality": "Gerrards Cross",
"region": "UK",
"postalCode": "SL90BG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07425909367"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-11335",
"name": "Chiesi Limited",
"identifier": {
"legalName": "Chiesi Limited"
},
"address": {
"streetAddress": "333 Styal Road",
"locality": "Manchester",
"region": "UK",
"postalCode": "M22 5LG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01614885526",
"faxNumber": "+44 01614885564"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-95762",
"name": "Mercury Pharmaceuticals Limited",
"identifier": {
"legalName": "Mercury Pharmaceuticals Limited"
},
"address": {
"streetAddress": "Dashwood House, , 2nd Floor, 69 Old Broad Street,",
"locality": "London, United Kingdom.",
"region": "UKI",
"postalCode": "EC2M 1QS",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 02085889335"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross",
"identifier": {
"legalName": "STADA UK - Thornton & Ross"
},
"address": {
"streetAddress": "Linthwaite",
"locality": "Huddersfield",
"region": "UK",
"postalCode": "HD7 5JN",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07979935409"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-26343",
"name": "CST Pharma Ltd",
"identifier": {
"legalName": "CST Pharma Ltd"
},
"address": {
"streetAddress": "Unit 5-7, Westgate Park Industrial Estate, Tintagel Way",
"locality": "Walsall",
"region": "UK",
"postalCode": "WS9 8ER",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01477549310"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd",
"identifier": {
"legalName": "Glenmark Pharmaceuticals Europe Ltd"
},
"address": {
"streetAddress": "Building 2, Croxley Green Business Park",
"locality": "Watford",
"region": "UK",
"postalCode": "WD18 8YA",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07538794897"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4564",
"name": "Kent Pharmaceuticals Ltd",
"identifier": {
"legalName": "Kent Pharmaceuticals Ltd"
},
"address": {
"streetAddress": "Joshna House, Crowbridge Road",
"locality": "Ashford",
"region": "UK",
"postalCode": "TN24 0GR",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01233506593",
"faxNumber": "+44 08454375567"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-95765",
"name": "Sandoz",
"identifier": {
"legalName": "Sandoz"
},
"address": {
"streetAddress": "Park View, Riverside Way, Watchmoor Park",
"locality": "Camberley, Surrey",
"region": "UK",
"postalCode": "GU15 3YL",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07766295207"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-95761",
"name": "Wockhardt UK Limited",
"identifier": {
"legalName": "Wockhardt UK Limited"
},
"address": {
"streetAddress": "Ash Road North, Wrexham Ind Estate, Wrexham",
"locality": "Wrexham",
"region": "UK",
"postalCode": "LL13 9UF",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01978661261",
"faxNumber": "+44 01978661262"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4557",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"streetAddress": "12 New Fetter Lane",
"locality": "london",
"region": "UK",
"postalCode": "EC4A 1JP",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 0800854431"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd.",
"identifier": {
"legalName": "Celix Pharma Ltd."
},
"address": {
"streetAddress": "12 Constance Street, International House",
"locality": "London",
"region": "UK",
"postalCode": "E16 2DQ",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07795600016"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146746",
"name": "Hikma Pharmaceutical International Limited",
"identifier": {
"legalName": "Hikma Pharmaceutical International Limited"
},
"address": {
"streetAddress": "1 New Burlington Place",
"locality": "London",
"region": "UK",
"postalCode": "W1S 2HR",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 7584021821"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-92096",
"name": "MSN Labs",
"identifier": {
"legalName": "MSN Labs"
},
"address": {
"streetAddress": "Works Road",
"locality": "LETCHWORTH GARDEN CITY",
"region": "UK",
"postalCode": "SG6 1GJ",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07789669333"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146747",
"name": "Perennial Pharma Ltd",
"identifier": {
"legalName": "Perennial Pharma Ltd"
},
"address": {
"streetAddress": "Titan Court, 2nd Floor, 3 Bishop Square",
"locality": "Hatfield",
"region": "UK",
"postalCode": "AL10 9NA",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07775675020"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd",
"identifier": {
"legalName": "Viatris UK Healthcare Ltd"
},
"address": {
"streetAddress": "Building 4, Trident Place, Mosquito Way",
"locality": "Hatfield",
"region": "UKH23",
"postalCode": "AL10 9UL",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07586494246"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-11340",
"name": "Bowmed Ibisqus Limited",
"identifier": {
"legalName": "Bowmed Ibisqus Limited"
},
"address": {
"streetAddress": "The Old Dairy, Brynkinalt Business Centre, Brynkinalt, Chirk",
"locality": "Wrexham",
"region": "UK",
"postalCode": "LL14 5NS",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 8456436703",
"faxNumber": "+44 7006053513"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146748",
"name": "Bristol Laboratories",
"identifier": {
"legalName": "Bristol Laboratories"
},
"address": {
"streetAddress": "Bristol House, Unit 3 Canal side , Northbridge Road",
"locality": "Berkhamsted",
"region": "UK",
"postalCode": "HP4 1EG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01442200922"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4548",
"name": "Consilient Health Ltd",
"identifier": {
"legalName": "Consilient Health Ltd"
},
"address": {
"streetAddress": "No. 1 Church Road , Richmond upon Thames .",
"locality": "Richmond",
"region": "UK",
"postalCode": "TW9 2QE",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 02037511888"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146749",
"name": "Galvany Pharma",
"identifier": {
"legalName": "Galvany Pharma"
},
"address": {
"streetAddress": "Business & Technology Centre, Bessemer Drive",
"locality": "Stevenage",
"region": "UKD",
"postalCode": "SG1 2DX",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07398135368"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146750",
"name": "Gennisium Pharma SAS",
"identifier": {
"legalName": "Gennisium Pharma SAS"
},
"address": {
"streetAddress": "Chemin de la Bastide Blanche, SWEN Parc de Vitrolles Batiment E",
"locality": "Vitrolles",
"region": "FRL",
"postalCode": "13127",
"countryName": "France"
},
"contactPoint": {
"telephone": "+49 1794075379"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146751",
"name": "Grindeks Kalceks",
"identifier": {
"legalName": "Grindeks Kalceks"
},
"address": {
"streetAddress": "Centrum Building, Norwich Research Park",
"locality": "Norwich",
"region": "UK",
"postalCode": "NR4 7UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07753579788"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-26341",
"name": "hameln pharma ltd",
"identifier": {
"legalName": "hameln pharma ltd"
},
"address": {
"streetAddress": "Unit C, Nexus, Gloucester Business Park",
"locality": "Gloucester",
"region": "UKK13",
"postalCode": "GL3 4AG",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01452621661",
"faxNumber": "+44 01452632732"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146752",
"name": "Macure Pharma Aps",
"identifier": {
"legalName": "Macure Pharma Aps"
},
"address": {
"streetAddress": "Hejrevej 39",
"locality": "Kobenhavn NV",
"region": "UK",
"postalCode": "2400",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+45 26369204"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-146753",
"name": "Morningside Pharmaceuticals Limited",
"identifier": {
"legalName": "Morningside Pharmaceuticals Limited"
},
"address": {
"streetAddress": "SECOND FLOOR, BOSS COURT, 7 BARTON CLOSE, GROVE PARK,",
"locality": "Leicester",
"region": "UK",
"postalCode": "LE19 1SJ",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 01509217705"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4555",
"name": "Ranbaxy (UK) Ltd",
"identifier": {
"legalName": "Ranbaxy (UK) Ltd"
},
"address": {
"streetAddress": "Building 4, Chiswick Park, 566 Chiswick High Road",
"locality": "London",
"region": "UK",
"postalCode": "W4 5YE",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4554",
"name": "Rosemont Pharmaceuticals Ltd",
"identifier": {
"legalName": "Rosemont Pharmaceuticals Ltd"
},
"address": {
"streetAddress": "Braithwaite Street, Leeds, West Yorkshire",
"locality": "Leeds",
"region": "UK",
"postalCode": "LS11 9XE",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-92089",
"name": "Stirling Anglian Pharmaceuticals",
"identifier": {
"legalName": "Stirling Anglian Pharmaceuticals"
},
"address": {
"streetAddress": "Hillington Park Innovation Centre, , 1 Ainslie Road,",
"locality": "Hillington Park, Glasgow",
"region": "UK",
"postalCode": "G52 4RU",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07887638369"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-146754",
"name": "SyriMed",
"identifier": {
"legalName": "SyriMed"
},
"address": {
"streetAddress": "Flat 2, 9 Grange Road",
"locality": "Kingston Upon Thames",
"region": "UK",
"postalCode": "KT1 2QU",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 07446941600"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000777704"
}
],
"language": "en",
"awards": [
{
"id": "019020-2025-1",
"relatedLots": [
"3"
],
"title": "Epinephrine (Adrenaline) Pre-Filled Syringes",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma"
},
{
"id": "GB-FTS-11339",
"name": "Aguettant Ltd"
}
]
},
{
"id": "019020-2025-2",
"relatedLots": [
"2"
],
"title": "Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11330",
"name": "GlaxoSmithKline"
}
]
},
{
"id": "019020-2025-3",
"relatedLots": [
"5"
],
"title": "Enoxaparin Sodium Injection",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11719",
"name": "Aventis Pharma Ltd t/a Sanofi"
},
{
"id": "GB-FTS-88174",
"name": "Day Lewis Medical Ltd"
},
{
"id": "GB-FTS-88176",
"name": "Techdow Pharma England Ltd"
},
{
"id": "GB-FTS-146745",
"name": "Venipharm LTD"
}
]
},
{
"id": "019020-2025-4",
"relatedLots": [
"7"
],
"title": "Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma"
},
{
"id": "GB-FTS-92087",
"name": "Accord"
},
{
"id": "GB-FTS-11335",
"name": "Chiesi Limited"
},
{
"id": "GB-FTS-95762",
"name": "Mercury Pharmaceuticals Limited"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
}
]
},
{
"id": "019020-2025-5",
"relatedLots": [
"8"
],
"title": "Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma"
},
{
"id": "GB-FTS-11719",
"name": "Aventis Pharma Ltd t/a Sanofi"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
},
{
"id": "GB-FTS-88174",
"name": "Day Lewis Medical Ltd"
}
]
},
{
"id": "019020-2025-6",
"relatedLots": [
"9"
],
"title": "Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd"
}
]
},
{
"id": "019020-2025-7",
"relatedLots": [
"12"
],
"title": "Branded and Branded Generic Inhalers",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-92087",
"name": "Accord"
},
{
"id": "GB-FTS-146744",
"name": "Aspire"
},
{
"id": "GB-FTS-11335",
"name": "Chiesi Limited"
},
{
"id": "GB-FTS-26343",
"name": "CST Pharma Ltd"
},
{
"id": "GB-FTS-88174",
"name": "Day Lewis Medical Ltd"
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-4564",
"name": "Kent Pharmaceuticals Ltd"
},
{
"id": "GB-FTS-95765",
"name": "Sandoz"
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
},
{
"id": "GB-FTS-95761",
"name": "Wockhardt UK Limited"
},
{
"id": "GB-FTS-11330",
"name": "GlaxoSmithKline"
}
]
},
{
"id": "019020-2025-8",
"relatedLots": [
"13"
],
"title": "Iloprost Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-88173",
"name": "Colonis Pharma Ltd"
},
{
"id": "GB-FTS-4557",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "019020-2025-9",
"relatedLots": [
"14"
],
"title": "Dalteparin Injections",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-33719",
"name": "Pfizer Limited"
}
]
},
{
"id": "019020-2025-10",
"relatedLots": [
"15"
],
"title": "Tinzaparin Sodium Injections",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-146743",
"name": "Northumbria Healthcare NHS Foundation Trust"
}
]
},
{
"id": "019020-2025-11",
"relatedLots": [
"16"
],
"title": "Icatibant Solution for Injection",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma"
},
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd."
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-146746",
"name": "Hikma Pharmaceutical International Limited"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
},
{
"id": "GB-FTS-95761",
"name": "Wockhardt UK Limited"
}
]
},
{
"id": "019020-2025-12",
"relatedLots": [
"17"
],
"title": "Treprostinil Injection",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd"
}
]
},
{
"id": "019020-2025-13",
"relatedLots": [
"18"
],
"title": "Direct Acting Oral Anticoagulants (DOACs)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-146744",
"name": "Aspire"
},
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd."
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-92096",
"name": "MSN Labs"
},
{
"id": "GB-FTS-146747",
"name": "Perennial Pharma Ltd"
},
{
"id": "GB-FTS-95765",
"name": "Sandoz"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd"
},
{
"id": "GB-FTS-95761",
"name": "Wockhardt UK Limited"
},
{
"id": "GB-FTS-4557",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "019020-2025-14",
"relatedLots": [
"19"
],
"title": "All Other Cardiovascular & Respiratory Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4565",
"name": "Martindale Pharma"
},
{
"id": "GB-FTS-92087",
"name": "Accord"
},
{
"id": "GB-FTS-11339",
"name": "Aguettant Ltd"
},
{
"id": "GB-FTS-146744",
"name": "Aspire"
},
{
"id": "GB-FTS-11719",
"name": "Aventis Pharma Ltd t/a Sanofi"
},
{
"id": "GB-FTS-11340",
"name": "Bowmed Ibisqus Limited"
},
{
"id": "GB-FTS-146748",
"name": "Bristol Laboratories"
},
{
"id": "GB-FTS-88173",
"name": "Colonis Pharma Ltd"
},
{
"id": "GB-FTS-4548",
"name": "Consilient Health Ltd"
},
{
"id": "GB-FTS-26343",
"name": "CST Pharma Ltd"
},
{
"id": "GB-FTS-88174",
"name": "Day Lewis Medical Ltd"
},
{
"id": "GB-FTS-11344",
"name": "Focus Pharmaceuticals Ltd"
},
{
"id": "GB-FTS-146749",
"name": "Galvany Pharma"
},
{
"id": "GB-FTS-146750",
"name": "Gennisium Pharma SAS"
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-146751",
"name": "Grindeks Kalceks"
},
{
"id": "GB-FTS-26341",
"name": "hameln pharma ltd"
},
{
"id": "GB-FTS-146746",
"name": "Hikma Pharmaceutical International Limited"
},
{
"id": "GB-FTS-4564",
"name": "Kent Pharmaceuticals Ltd"
},
{
"id": "GB-FTS-146752",
"name": "Macure Pharma Aps"
},
{
"id": "GB-FTS-95762",
"name": "Mercury Pharmaceuticals Limited"
},
{
"id": "GB-FTS-146753",
"name": "Morningside Pharmaceuticals Limited"
},
{
"id": "GB-FTS-92096",
"name": "MSN Labs"
},
{
"id": "GB-FTS-33719",
"name": "Pfizer Limited"
},
{
"id": "GB-FTS-4555",
"name": "Ranbaxy (UK) Ltd"
},
{
"id": "GB-FTS-4554",
"name": "Rosemont Pharmaceuticals Ltd"
},
{
"id": "GB-FTS-95765",
"name": "Sandoz"
},
{
"id": "GB-FTS-92089",
"name": "Stirling Anglian Pharmaceuticals"
},
{
"id": "GB-FTS-146754",
"name": "SyriMed"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd"
},
{
"id": "GB-FTS-95761",
"name": "Wockhardt UK Limited"
},
{
"id": "GB-FTS-4557",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "019020-2025-15",
"relatedLots": [
"10"
],
"title": "Nifedipine Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11344",
"name": "Focus Pharmaceuticals Ltd"
},
{
"id": "GB-FTS-111739",
"name": "STADA UK - Thornton & Ross"
}
]
}
],
"contracts": [
{
"id": "019020-2025-1",
"awardID": "019020-2025-1",
"title": "Epinephrine (Adrenaline) Pre-Filled Syringes",
"status": "active",
"value": {
"amount": 1575630,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-2",
"awardID": "019020-2025-2",
"title": "Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials",
"status": "active",
"value": {
"amount": 10789555,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-3",
"awardID": "019020-2025-3",
"title": "Enoxaparin Sodium Injection",
"status": "active",
"value": {
"amount": 9947020,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-4",
"awardID": "019020-2025-4",
"title": "Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"value": {
"amount": 53405,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-5",
"awardID": "019020-2025-5",
"title": "Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"value": {
"amount": 81720,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-6",
"awardID": "019020-2025-6",
"title": "Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"value": {
"amount": 37695,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-7",
"awardID": "019020-2025-7",
"title": "Branded and Branded Generic Inhalers",
"status": "active",
"value": {
"amount": 2961460,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-8",
"awardID": "019020-2025-8",
"title": "Iloprost Medicines",
"status": "active",
"value": {
"amount": 257595,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-9",
"awardID": "019020-2025-9",
"title": "Dalteparin Injections",
"status": "active",
"value": {
"amount": 30489875,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-10",
"awardID": "019020-2025-10",
"title": "Tinzaparin Sodium Injections",
"status": "active",
"value": {
"amount": 848290,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-11",
"awardID": "019020-2025-11",
"title": "Icatibant Solution for Injection",
"status": "active",
"value": {
"amount": 170315,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-12",
"awardID": "019020-2025-12",
"title": "Treprostinil Injection",
"status": "active",
"value": {
"amount": 223250,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-13",
"awardID": "019020-2025-13",
"title": "Direct Acting Oral Anticoagulants (DOACs)",
"status": "active",
"value": {
"amount": 446140,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-14",
"awardID": "019020-2025-14",
"title": "All Other Cardiovascular & Respiratory Medicines",
"status": "active",
"value": {
"amount": 24410075,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
},
{
"id": "019020-2025-15",
"awardID": "019020-2025-15",
"title": "Nifedipine Modified-Release (M/R) Capsules and Tablets",
"status": "active",
"value": {
"amount": 13855,
"currency": "GBP"
},
"dateSigned": "2025-04-07T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "76",
"measure": "bids",
"relatedLot": "3",
"value": 2
},
{
"id": "81",
"measure": "bids",
"relatedLot": "2",
"value": 2
},
{
"id": "86",
"measure": "bids",
"relatedLot": "5",
"value": 4
},
{
"id": "91",
"measure": "bids",
"relatedLot": "7",
"value": 5
},
{
"id": "96",
"measure": "bids",
"relatedLot": "8",
"value": 4
},
{
"id": "101",
"measure": "bids",
"relatedLot": "9",
"value": 1
},
{
"id": "106",
"measure": "bids",
"relatedLot": "12",
"value": 12
},
{
"id": "111",
"measure": "bids",
"relatedLot": "13",
"value": 2
},
{
"id": "116",
"measure": "bids",
"relatedLot": "14",
"value": 1
},
{
"id": "121",
"measure": "bids",
"relatedLot": "15",
"value": 2
},
{
"id": "126",
"measure": "bids",
"relatedLot": "16",
"value": 6
},
{
"id": "131",
"measure": "bids",
"relatedLot": "17",
"value": 1
},
{
"id": "136",
"measure": "bids",
"relatedLot": "18",
"value": 11
},
{
"id": "141",
"measure": "bids",
"relatedLot": "19",
"value": 42
},
{
"id": "146",
"measure": "bids",
"relatedLot": "10",
"value": 3
},
{
"id": "77",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "82",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "87",
"measure": "smeBids",
"relatedLot": "5",
"value": 0
},
{
"id": "92",
"measure": "smeBids",
"relatedLot": "7",
"value": 0
},
{
"id": "97",
"measure": "smeBids",
"relatedLot": "8",
"value": 0
},
{
"id": "102",
"measure": "smeBids",
"relatedLot": "9",
"value": 0
},
{
"id": "107",
"measure": "smeBids",
"relatedLot": "12",
"value": 0
},
{
"id": "112",
"measure": "smeBids",
"relatedLot": "13",
"value": 0
},
{
"id": "117",
"measure": "smeBids",
"relatedLot": "14",
"value": 0
},
{
"id": "122",
"measure": "smeBids",
"relatedLot": "15",
"value": 0
},
{
"id": "127",
"measure": "smeBids",
"relatedLot": "16",
"value": 0
},
{
"id": "132",
"measure": "smeBids",
"relatedLot": "17",
"value": 0
},
{
"id": "137",
"measure": "smeBids",
"relatedLot": "18",
"value": 0
},
{
"id": "142",
"measure": "smeBids",
"relatedLot": "19",
"value": 0
},
{
"id": "147",
"measure": "smeBids",
"relatedLot": "10",
"value": 0
},
{
"id": "78",
"measure": "foreignBidsFromEU",
"relatedLot": "3",
"value": 0
},
{
"id": "83",
"measure": "foreignBidsFromEU",
"relatedLot": "2",
"value": 0
},
{
"id": "88",
"measure": "foreignBidsFromEU",
"relatedLot": "5",
"value": 0
},
{
"id": "93",
"measure": "foreignBidsFromEU",
"relatedLot": "7",
"value": 0
},
{
"id": "98",
"measure": "foreignBidsFromEU",
"relatedLot": "8",
"value": 0
},
{
"id": "103",
"measure": "foreignBidsFromEU",
"relatedLot": "9",
"value": 0
},
{
"id": "108",
"measure": "foreignBidsFromEU",
"relatedLot": "12",
"value": 0
},
{
"id": "113",
"measure": "foreignBidsFromEU",
"relatedLot": "13",
"value": 0
},
{
"id": "118",
"measure": "foreignBidsFromEU",
"relatedLot": "14",
"value": 0
},
{
"id": "123",
"measure": "foreignBidsFromEU",
"relatedLot": "15",
"value": 0
},
{
"id": "128",
"measure": "foreignBidsFromEU",
"relatedLot": "16",
"value": 0
},
{
"id": "133",
"measure": "foreignBidsFromEU",
"relatedLot": "17",
"value": 0
},
{
"id": "138",
"measure": "foreignBidsFromEU",
"relatedLot": "18",
"value": 0
},
{
"id": "143",
"measure": "foreignBidsFromEU",
"relatedLot": "19",
"value": 0
},
{
"id": "148",
"measure": "foreignBidsFromEU",
"relatedLot": "10",
"value": 0
},
{
"id": "79",
"measure": "foreignBidsFromNonEU",
"relatedLot": "3",
"value": 2
},
{
"id": "84",
"measure": "foreignBidsFromNonEU",
"relatedLot": "2",
"value": 2
},
{
"id": "89",
"measure": "foreignBidsFromNonEU",
"relatedLot": "5",
"value": 4
},
{
"id": "94",
"measure": "foreignBidsFromNonEU",
"relatedLot": "7",
"value": 5
},
{
"id": "99",
"measure": "foreignBidsFromNonEU",
"relatedLot": "8",
"value": 4
},
{
"id": "104",
"measure": "foreignBidsFromNonEU",
"relatedLot": "9",
"value": 1
},
{
"id": "109",
"measure": "foreignBidsFromNonEU",
"relatedLot": "12",
"value": 12
},
{
"id": "114",
"measure": "foreignBidsFromNonEU",
"relatedLot": "13",
"value": 2
},
{
"id": "119",
"measure": "foreignBidsFromNonEU",
"relatedLot": "14",
"value": 1
},
{
"id": "124",
"measure": "foreignBidsFromNonEU",
"relatedLot": "15",
"value": 2
},
{
"id": "129",
"measure": "foreignBidsFromNonEU",
"relatedLot": "16",
"value": 6
},
{
"id": "134",
"measure": "foreignBidsFromNonEU",
"relatedLot": "17",
"value": 1
},
{
"id": "139",
"measure": "foreignBidsFromNonEU",
"relatedLot": "18",
"value": 11
},
{
"id": "144",
"measure": "foreignBidsFromNonEU",
"relatedLot": "19",
"value": 42
},
{
"id": "149",
"measure": "foreignBidsFromNonEU",
"relatedLot": "10",
"value": 3
},
{
"id": "80",
"measure": "electronicBids",
"relatedLot": "3",
"value": 2
},
{
"id": "85",
"measure": "electronicBids",
"relatedLot": "2",
"value": 2
},
{
"id": "90",
"measure": "electronicBids",
"relatedLot": "5",
"value": 4
},
{
"id": "95",
"measure": "electronicBids",
"relatedLot": "7",
"value": 5
},
{
"id": "100",
"measure": "electronicBids",
"relatedLot": "8",
"value": 4
},
{
"id": "105",
"measure": "electronicBids",
"relatedLot": "9",
"value": 1
},
{
"id": "110",
"measure": "electronicBids",
"relatedLot": "12",
"value": 12
},
{
"id": "115",
"measure": "electronicBids",
"relatedLot": "13",
"value": 2
},
{
"id": "120",
"measure": "electronicBids",
"relatedLot": "14",
"value": 1
},
{
"id": "125",
"measure": "electronicBids",
"relatedLot": "15",
"value": 2
},
{
"id": "130",
"measure": "electronicBids",
"relatedLot": "16",
"value": 6
},
{
"id": "135",
"measure": "electronicBids",
"relatedLot": "17",
"value": 1
},
{
"id": "140",
"measure": "electronicBids",
"relatedLot": "18",
"value": 11
},
{
"id": "145",
"measure": "electronicBids",
"relatedLot": "19",
"value": 42
},
{
"id": "150",
"measure": "electronicBids",
"relatedLot": "10",
"value": 3
}
]
}
}